Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG

(EUZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the Nine Months Ended September 30, 2021

11/09/2021 | 02:45am EST

Eckert & Ziegler Strahlen- und Medizintechnik AG reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was EUR 131.02 million compared to EUR 126.89 million a year ago. Net income was EUR 29.24 million compared to EUR 17.72 million a year ago. Basic earnings per share from continuing operations was EUR 1.41 compared to EUR 0.86 a year ago. Diluted earnings per share from continuing operations was EUR 1.41 compared to EUR 0.86 a year ago.


ę S&P Capital IQ 2021
All news about ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
01/11ECKERT & ZIEGLER STRAHLEN- UND MEDIZ : Notification and public disclosure of transactions ..
EQ
01/11Eckert & Ziegler Unit Enters Supply Deal for Ytterbium-176 Isotope with US Firm; Shares..
MT
01/10Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176
EQ
01/03Eckert & Ziegler Buys Argentinian Nuclear Medicine Firm Tecnonuclear
MT
01/03???????Eckert & Ziegler Acquires Argentinian SPECT Specialist
EQ
01/03Eckert & Ziegler Strahlen- und Medizintechnik AG acquired Tecnonuclear S. A.
CI
2021Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIX..
EQ
2021ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Declaration on the Corporate Governance Code 2021
PU
2021Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil
EQ
2021Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil
CI
More news
Analyst Recommendations on ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
More recommendations
Financials
Sales 2021 180 M 204 M 204 M
Net income 2021 26,9 M 30,5 M 30,5 M
Net cash 2021 96,9 M 110 M 110 M
P/E ratio 2021 60,6x
Yield 2021 0,55%
Capitalization 1 648 M 1 869 M 1 869 M
EV / Sales 2021 8,64x
EV / Sales 2022 6,76x
Nbr of Employees 841
Free-Float -
Chart ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Duration : Period :
Eckert & Ziegler Strahlen- und Medizintechnik AG Technical Analysis Chart | EUZ | DE0005659700 | MarketScreener
Technical analysis trends ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 79,40 €
Average target price 172,00 €
Spread / Average Target 117%
EPS Revisions
Managers and Directors
Andreas Eckert Chairman-Executive Board
Wolfgang Maennig Chairman-Supervisory Board
Helmut Grothe Vice Chairman-Supervisory Board
Albert Rupprecht Member-Supervisory Board
Edgar L÷ffler Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG-12.91%1 929
JOHNSON & JOHNSON-3.40%435 037
ROCHE HOLDING AG-3.69%322 260
PFIZER, INC.-8.47%303 375
ABBVIE INC.-1.75%235 181
NOVO NORDISK A/S-13.40%220 833